Seiichiro Katagiri

10PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesMolecular targetsMedical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 19, 2023
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy.

Seiichiro Katagiri, Nahoko Furuya, Daigo Akahane

|Sep 23, 2022
Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study.

Seiichiro Katagiri, Daigo Akahane, Shunsuke Otsuki

|Jul 18, 2022
Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatment.

Mitsuru Moriyama, Yasuo Aota, Masahiro Okabe

|May 14, 2022
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.

Seiichiro Katagiri, SungGi Chi, Yosuke Minami

|Sep 12, 2020
Successful cord blood transplantation for myelodysplastic syndrome complicated by Mycobacterium kansasii pneumonia.

Arisa Yamada, Daigo Akahane, Seiichiro Katagiri

|Apr 29, 2020
Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.

Takako Yokomizo-Nakano, Sho Kubota, Jie Bai

Pageof 2

Frequent Collaborators

6 joint publications

Akihiko Gotoh

3 joint publications

Daigo Akahane

1 joint publications

Kazuma Ohyashiki

1 joint publications

Takako Yokomizo-Nakano